Horizon Tries To Thwart Par's Plans For Arthritis Generic
Horizon Pharma Inc. hit Par Pharmaceutical Cos. Inc. with a patent infringement lawsuit Monday in Delaware federal court over Par's plans to produce a generic version of the arthritis medication Duexis....To view the full article, register now.
Already a subscriber? Click here to view full article